Description
A CDK7 inhibitor (IC50 = 50s = >10, >10, and 1.71 μM); inhibits CDK2 and CDK1 (IC50s = 6.4 and 53.7 nM, respectively); induces apoptosis in A549, HeLa, and HCT116 cancer cells from 10-100 nM; inhibits HCMV replication in human fibroblasts (EC50 = 24.5 nM); reduces replication of various viruses (EC50s = 0.02-1.13 μM)
Formal name: 8-(1-methylethyl)-2-(3-piperidinyloxy)-N-[[2-(1H-pyrazol-1-yl)phenyl]methyl]-pyrazolo[1,5-a]-1,3,5-triazin-4-amine
Synonyms:
Molecular weight: 432.5
CAS: 1453834-21-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals||Product Type|Biochemicals|Kinase Inhibitors|CDKs||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Cycle||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Cell Signaling||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|HSV